Treating schizophrenia with essential fatty acid compositions

Details Treating schizophrenia with essential fatty acid compositions Treating schizophrenia with essential fatty acid compositions

1989-06-01

1990-12-11

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

A61K 3120

Patent

active

049771876

ABSTRACT:
Method of, and preparations of medicaments for, treating schizophrenia and/or associated tardive dyskinesia by combining an essential fatty acid selected from GLA and higher N-6 series acids with an essential fatty acid selected from stearidonic acid and higher n-3 series acids in effective daily amounts of 10 mg and 50 g of each acid.

REFERENCES:
patent: 4273763 (1981-06-01), Harrobin
patent: 4302447 (1981-11-01), Harrobin

Affiliated with

Also associated with

Rating

Treating schizophrenia with essential fatty acid compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating schizophrenia with essential fatty acid compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating schizophrenia with essential fatty acid compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-390655